Skip to main content
Equibles
NMRA logo

NMRA · Neumora Therapeutics, Inc. · Suppliers & Customers

Track NMRA — free

Use NMRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NMRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.37 -0.02 (-5.43%) At close · Oct 30 Q4 2025 earnings call transcript
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“While the Company expects to be able to obtain additional funding, the current available cash and cash equivalents will not be sufficient to fund the Company’s operating plans for at least twelve months from the issuance date of these condensed consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$69.00M
Shares
187.90M
Volume · Oct 30 1.11M Avg daily vol (3M) 1.45M

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones NMRA names, and the companies that name NMRA.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who NMRA sells to, buys from and competes with

  • 0 suppliers
  • 0 customers
  • 10 competitors

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1885522 CUSIP 640979100 13F (30d) 22 filings 22 filers Visit website Investor relations